Improvement of the methods for oligonucleotide: delivery into cells is nece
ssary for the development of antisense therapy. In the present work, a new
strategy for oligonucleotide delivery into cells was tested using cationic
peptides as a vector. At first, to understand what structure of the peptide
is required for binding with an oligonucleotide, several kinds of alpha-he
lical and non-alpha-helical peptides containing cationic amino acids were e
mployed. As a result, the amphiphilic: alpha-helix peptides were best for b
inding with the oligonucleotide, and the long chain length and large hydrop
hobic region in the amphiphilic structure of the peptide were necessary for
the binding and forming of aggregates with the oligonucleotide. In the cas
e of non-alpha-helical peptides, no significant binding ability was observe
d even if their chain lengths and number of cationic amino acid residues we
re equal to those of the alpha-helical peptides. The remarkable ability of
oligonucleotide delivery into COS-7 cells was observed in the alpha-helical
peptides with a long chain length and large hydrophobic region in the amph
iphilic structure, but was not observed in the non-alpha-helical peptides.
It is considered that such cc-helical peptides could form optimum aggregate
s with the ODN for uptake into cells. Based on these results, the alpha-hel
ical peptide with a long chain length and large hydrophobic region is appli
cable as a vector for the delivery of oligonucleotides into cells. Copyrigh
t (C) 2000 European Peptide Society and John Wiley gr Sons, Ltd.